Patents by Inventor Benxian Liu

Benxian Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8053408
    Abstract: The present invention provides methods for reducing body weight in a mammal using Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same.
    Type: Grant
    Filed: March 10, 2010
    Date of Patent: November 8, 2011
    Assignee: Amgen Inc.
    Inventors: Arlen Thomason, Benxian Liu
  • Patent number: 8044024
    Abstract: The present invention provides novel Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing FGF-like polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with FGF-like polypeptides.
    Type: Grant
    Filed: June 1, 2010
    Date of Patent: October 25, 2011
    Assignee: Amgen Inc.
    Inventors: Arlen Read Thomason, Benxian Liu
  • Patent number: 8030275
    Abstract: The present invention provides methods for reducing body weight in a mammal using Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same.
    Type: Grant
    Filed: March 10, 2010
    Date of Patent: October 4, 2011
    Assignee: Amgen Inc.
    Inventors: Arlen Thomason, Benxian Liu
  • Patent number: 7887799
    Abstract: The present invention provides novel Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing FGF-like polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with FGF-like polypeptides.
    Type: Grant
    Filed: November 13, 2008
    Date of Patent: February 15, 2011
    Assignee: Amgen Inc.
    Inventors: Arlen Thomason, Benxian Liu
  • Patent number: 7879323
    Abstract: The present invention provides novel Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing FGF-like polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with FGF-like polypeptides.
    Type: Grant
    Filed: November 13, 2008
    Date of Patent: February 1, 2011
    Assignee: Amgen Inc.
    Inventors: Arlen Thomason, Benxian Liu
  • Publication number: 20110003302
    Abstract: The present invention provides novel Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing FGF-like polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with FGF-like polypeptides.
    Type: Application
    Filed: June 1, 2010
    Publication date: January 6, 2011
    Applicant: AMGEN INC.
    Inventors: Arlen Read Thomason, Benxian Liu
  • Publication number: 20100310566
    Abstract: The present invention provides novel Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing FGF-like polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with FGF-like polypeptides.
    Type: Application
    Filed: June 1, 2010
    Publication date: December 9, 2010
    Applicant: AMGEN INC.
    Inventors: Arlen Read Thomason, Benxian Liu
  • Publication number: 20100233169
    Abstract: The present invention provides novel Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing FGF-like polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with FGF-like polypeptides.
    Type: Application
    Filed: March 10, 2010
    Publication date: September 16, 2010
    Inventors: Arlen Thomason, Benxian Liu
  • Publication number: 20100226921
    Abstract: The present invention provides novel Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing FGF-like polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with FGF-like polypeptides.
    Type: Application
    Filed: March 10, 2010
    Publication date: September 9, 2010
    Inventors: Arlen Thomason, Benxian Liu
  • Patent number: 7727742
    Abstract: The present invention provides nucleic acid molecules encoding Fibroblast Growth Factor-like (FGF-like) polypeptides. The invention also provides vectors, host cells, and methods for producing FGF-like polypeptides.
    Type: Grant
    Filed: June 27, 2008
    Date of Patent: June 1, 2010
    Assignee: Amgen Inc.
    Inventors: Arlen Thomason, Benxian Liu
  • Patent number: 7704952
    Abstract: The present invention provides methods for treating diabetes using Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same.
    Type: Grant
    Filed: June 27, 2008
    Date of Patent: April 27, 2010
    Assignee: Amgen Inc.
    Inventors: Arlen Thomason, Benxian Liu
  • Patent number: 7700558
    Abstract: The present invention provides methods for treating diabetes using Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same.
    Type: Grant
    Filed: June 27, 2008
    Date of Patent: April 20, 2010
    Assignee: Amgen Inc.
    Inventors: Arlen Thomason, Benxian Liu
  • Patent number: 7696172
    Abstract: The present invention provides Fibroblast Growth Factor-like (FGF-like) polypeptides, nucleic acid molecules encoding the same, and variants thereof.
    Type: Grant
    Filed: June 27, 2008
    Date of Patent: April 13, 2010
    Assignee: Amgen Inc.
    Inventors: Arlen Thomason, Benxian Liu
  • Patent number: 7695938
    Abstract: The present invention provides vectors and recombinant host cells comprising nucleic acid molecules encoding Fibroblast Growth Factor-like (FGF-like) polypeptides. The invention also provides methods for producing FGF-like polypeptides using such recombinant host cells.
    Type: Grant
    Filed: November 13, 2008
    Date of Patent: April 13, 2010
    Assignee: Amgen Inc.
    Inventors: Arlen Thomason, Benxian Liu
  • Patent number: 7671180
    Abstract: The present invention provides novel Fibroblast Growth Factor-like (FGF-like) fusion polypedtides.
    Type: Grant
    Filed: April 11, 2007
    Date of Patent: March 2, 2010
    Assignee: Amgen, Inc.
    Inventors: Arlen Thomason, Benxian Liu
  • Patent number: 7667008
    Abstract: The present invention provides novel Fibroblast Growth Factor-like (FGF-like) fusion polypeptides.
    Type: Grant
    Filed: April 11, 2007
    Date of Patent: February 23, 2010
    Assignee: Amgen, Inc.
    Inventors: Arlen Thomason, Benxian Liu
  • Publication number: 20100028349
    Abstract: The present invention provides novel Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing FGF-like polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with FGF-like polypeptides.
    Type: Application
    Filed: November 13, 2008
    Publication date: February 4, 2010
    Applicant: AMGEN INC.
    Inventors: Arlen Thomason, Benxian Liu, Dimitry Michael Danilenko
  • Publication number: 20090324599
    Abstract: The present invention provides novel Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing FGF-like polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with FGF-like polypeptides.
    Type: Application
    Filed: November 13, 2008
    Publication date: December 31, 2009
    Applicant: AMGEN INC.
    Inventors: Arlen Thomason, Benxian Liu
  • Publication number: 20090148885
    Abstract: The present invention provides novel Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing FGF-like polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with FGF-like polypeptides.
    Type: Application
    Filed: November 13, 2008
    Publication date: June 11, 2009
    Applicant: AMGEN, INC.
    Inventors: Arlen Thomason, Benxian Liu, Dimitry Michael Danilenko
  • Publication number: 20090118182
    Abstract: The present invention provides novel Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing FGF-like polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with FGF-like polypeptides.
    Type: Application
    Filed: June 27, 2008
    Publication date: May 7, 2009
    Applicant: AMGEN, INC.
    Inventors: Arlen Thomason, Benxian Liu